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Abstract 
Due to its restricted localisation t  the neuromuscular junction and based on sequence homology to cytoskeletal proteins, the 
dystrophin-related protein utrophin is thought o be an important constituent of the membrane cytoskeleton of the postsynaptic muscle 
membrane and may be involved in the clustering of acetylcholine receptors at the neuromuscular junction. However, du  to the low 
density of utrophin in microsomal muscle membranes, it is difficult to analyse the biochemical properties of the skeletal muscle isoform 
of utrophin. To overcome these technical difficulties, we used here immunoblot analysis of highly purified muscle surface membranes 
enriched even in sarcolemma markers of very low density such as ecto-5'nucleotidase nd the calmodulin-sensitive Ca2+-ATPase. hi  
enabled us to analyse the membrane biochemical properties of this dystrophin isoform of extremely low abundance. Since alkaline 
treatment released utrophin from the bilayer while it stayed associated with the insoluble pellet following detergent extraction, utrophin 
exhibits biochemical properties typical of a membrane cytoskeletal protein. Therefore, utrophin appears to be a specialised isoform which 
performs the membrane cytoskeletal function(s) of dystrophin at the postsynaptic membrane of the neuromuscular junction. 
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1. Introduction 
Following the discovery of the genetic defect underly- 
ing Duchenne muscular dystrophy and the identification of 
its expressed product, the actin-binding protein dystrophin, 
studies into dystrophin-associated and dystrophin-related 
proteins have decisively enhanced our understanding of the 
molecular mechanisms causing inherited neuromuscular 
disorders [1-5]. It is now well established that primary 
defects in individual members of the dystrophin-glyco- 
protein complex result in muscle fibres which are more 
susceptible to cell necrosis [6-10]. One of the major 
functions of the dystrophin-glycoprotein complex in nor- 
mal muscle appears to be the transmembrane linkage 
between the extracellular matrix and the cortical actin 
membrane cytoskeleton in order to stabilise the muscle 
periphery during contraction [11]. However, numerous 
studies into dystrophin isoforms have now established that 
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certain members of this large family of proteins do not 
appear to function as actin-binding proteins [12]. As com- 
pared to the membrane cytoskeletal muscle dystrophin of 
427 kDa, alternative promotors are employed in the tran- 
scription of the genes encoding non-skeletal muscle dys- 
trophin isoforms such as the apo-dystrophins Dp45, Dp71 
and Dp116, as well as the 427 kDa isoforms found in brain 
and heart [2,12]. In contrast, a second class of dystrophin 
isoforms is autosomally encoded and represented by the 
dystrophin-related-proteins utrophin and G-utrophin [13- 
19], which also exist in non-muscle tissues [16-19]. 
The chromosome-6 encoded skeletal muscle utrophin is 
similar in size to the 427 kDa dystrophin and exhibits an 
apparent molecular mass of 395 kDa [15]. Due to the high 
sequence homology between utrophin and dystrophin over 
the entire length of the open reading frames, it was sug- 
gested that both molecules derive from a common ances- 
tral gene and that both proteins probably share functional 
domains important for interactions with the extracellular 
matrix and the subsarcolemmal membrane cytoskeleton 
[3,15]. While dystrophin is relatively evenly distributed 
over the entire surface membrane of normal muscle fibres, 
utrophin localisation is restricted to neuromuscular junc- 
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tions of adult skeletal muscle [20-22]. In analogy to the 
dystrophin-glycoprotein complex in the sarcolemma, 
utrophin also exists as a complex, tightly associated with 
several glycoproteins in the neuromuscular junction [23]. It 
was recently established that alpha-dystroglycan, a dys- 
trophin/utrophin-associated glycoprotein of 156 kDa, is a 
functional receptor for agrin [24-26]. Since agrin is a 
protein believed to be essential for synaptic specialisation 
and clustering of acetycholine receptors, utrophin was 
postulated to be the membrane cytoskeletal component 
responsible for acetylcholine receptor anchoring as re- 
viewed by Apel and Merlie [27]. Based on these recent 
findings and the sequence homology of utrophin with 
cytoskeletal proteins, it was of interest to establish that this 
dystrophin isoform indeed exhibits biochemical properties 
characteristic of a membrane cytoskeletal protein. 
A comparative analysis of the biochemical properties of 
dystrophin and utrophin is also of importance with respect 
to potential therapies aimed at the replacement of the 
dystrophin-glycoprotein complex in dystrophic muscle fi- 
bres. As compared to normal human skeletal muscle, 
dystrophic and regenerating skeletal muscle fibres exhibit 
utrophin staining also in the extra-junctional regions of the 
surface membrane [28] and thus, muscle biopsies from 
patients afflicted with Duchenne muscular dystrophy ex- 
hibit greatly increased amounts of utrophin [9,29]. It was 
proposed by Tinsley and Davies [30] that the up-regulation 
of utrophin might provide a therapeutical route to strength- 
ening the sarcolemmal integrity in dystrophin-deficient 
muscle fibres of patients uffering from muscular dystro- 
phies. To properly function as a replacement for dys- 
trophin, utrophin has to exhibit the same or at least closely 
related properties with respect o actin binding [31] and 
association with sarcolemmal glycoproteins [23]. Conse- 
quently, a comparative biochemical analysis of dystrophin 
and utrophin as presented in this study might provide a 
good indication of how these two isoforms are related 
concerning membrane cytoskeletal properties. 
However, to perform an analysis of utrophin, the isola- 
tion of a surface membrane fraction enriched in this low 
abundance dystrophin isoform is necessary. Skeletal mus- 
cle microsomes contain a complex mixture of membranes 
derived from the sarcolemma nd its elaborate invagina- 
tions, the transverse tubular membrane system, as well as 
the highly abundant sarcoplasmic reticulum and spe- 
cialised junctional triad couplings between a central trans- 
verse tubule and two terminal cisternae of the sarcoplasmic 
reticulum [32]. Thus, in order to prepare a muscle mem- 
brane fraction highly enriched in sarcolemma vesicles, we 
used lectin agglutination and a low detergent washing step. 
We found these surface membrane vesicles uitable for the 
above described application since they contained an en- 
richment in extremely low abundance plasma membrane 
markers such as ecto-5'nucleotidase and calmodulin-de- 
pendent CaZ+-ATPase. In addition, an important pre- 
requisite for the analysis of utrophin is the existence of 
highly specific antibodies which can differentiate between 
isoforms of dystrophin. It was previously shown that affin- 
ity-purified antibodies to the C-termini of dystrophin and 
utrophin do not cross-react with each other [20] and are 
therefore suitable in the comparative analysis of the two 
isoforms as shown in this study. 
2. Experimental procedures 
2.1. Materials 
Wheat germ agglutinin, protease inhibitors, Ponceau-S- 
Red and Coomassie brilliant blue solutions were purchased 
from Sigma (Dorset, UK). Prestained molecular mass 
markers were obtained from Bethesda Research Laborato- 
ries (Gaithersburg, MD). Nitrocellulose membranes w re 
purchased from Hoefer Scientific Instruments (San Fran- 
cisco, CA). Peroxidase-conjugated, secondary antibodies 
were from Boehringer-Mannheim (East Sussex, UK). All 
other reagents used in membrane isolation, gel elec- 
trophoresis and immunoblotting were of analytical grade. 
2.2. Antibodies 
Affinity-purified, polyclonal antibodies to dystrophin 
and utrophin [20], as well as monoclonal antibody IIID5 to 
the oLj-subunit of the dihydropyridine r ceptor [33] were 
generous gifts from Kevin P. Campbell (University of 
Iowa). Monoclonal antibody McB2 to the Na+/K +- 
ATPase [34] and polyclonal antibody to the ecto-5'nucleo- 
tidase [35] were generous gifts from Kathleen J. Sweadner 
(Massachusetts General Hospital) and Yukio Ikehara 
(Fukuoka University), respectively. A monoclonal anti- 
body to the dystrophin-associated glycoprotein of 43 kDa 
was purchased from Novocastra L boratories (Newcastle 
upon Tyne, UK). The polyclonal antibody to the glucose 
transporter was from Upstate Biotechnology Incorporated 
(Lake Placid, NY). A monoclonal antibody to the calmod- 
ulin-sensitive Ca2+-ATPase was obtained from Sigma 
(Dorset, UK). 
2.3. Isolation of muscle membranes 
Skeletal muscle from adult New Zealand white rabbits 
was trimmed of fat, minced with fine scissors and ho- 
mogenised in a cold room using a Kenwood BL-900 mixer 
at the maximum setting for 4 X 20s. All preparative steps 
were performed at 0-4°C and all buffers were supple- 
mented with a protease inhibitor cocktail (1 o~M each of: 
phenylmethanesulfonyl fluoride, aprotinin, soybean trypsin 
inhibitor, antipain, leupeptin, pepstatin A, and benzami- 
dine). KCl-washed microsomes were prepared by standard 
differential centrifugation [33] and a membrane fraction 
containing crude surface vesicles was isolated using cen- 
trifugation through a sucrose cushion as previously de- 
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scribed in detail [33]. Purified wheat germ agglutinin was 
resuspended at a concentration of 2 mg protein/ml in 
phosphate-buffered saline (50 mM sodium phosphate, pH 
7.4, 0.15 M NaC1) and incubated with an equal volume of 
crude surface membrane vesicles (2 mg protein/ml) [33]. 
Agglutinated vesicles were s parated by centrifugation i  a 
refrigerated Eppendorf centrifuge at 14000 X g for 1 rain, 
washed twice by resuspending them in phosphate-buffered 
saline and centrifugation performed as described above. 
Detergent washing was performed by treating lectin-ag- 
glutinated vesicles for 2 min on ice with 0.05% (v/v)  
Triton X-100 in 10% (w/v) sucrose, 20 mM Tris-HC1, pH 
7.4 [36]. Following detergent reatment, vesicles were 
washed three times as described above. For comparative 
immunoblot analysis, membrane vesicles derived from the 
sarcoplasmic reticulum, triads and the transverse tubules 
were prepared by standard ensity gradient centrifugation 
methods [37-39]. 
2.4. Alkaline extraction and detergent treatment 
3. Results 
3. I. Isolation of highly purified sarcolemma vesicles 
The flow chart in Fig. 1 summarises the different steps 
in the isolation of highly purified sarcolemma vesicles as 
presented in this manuscript. Crude microsomal mem- 
branes are prepared by standard ifferential centrifugation, 
followed by washing with 0.6 M KC1 to remove contami- 
nating actomyosin. A simple one-step centrifugation 
through a sucrose cushion is then employed to remove 
excess sarcoplasmic reticulum vesicles from the crude 
surface membrane preparation. Subsequently, sarcolemma 
vesicles are specifically agglutinated using purified wheat 
germ agglutinin [33]. Contaminating vesicles, trapped 
within the immobilised surface membrane vesicles, can be 
removed by incubation with low concentrations of a non- 
ionic detergent such as Triton X-100. The Coomassie- 
stained gel of Fig. 2 demonstrates the marked differences 
in the overall protein pattern of the four major types of 
muscle membranes which can be separated according to 
To characterise purified sarcolemma, isolated vesicles 
were treated in the presence of the above described mix- 
ture of protease inhibitors at a concentration of 1 mg 
protein/ml with an alkaline solution or non-ionic deter- 
gent. Alkaline extraction was performed for 1 h at room 
temperature with 20 mM Tris, pH 1l, 0.303 M sucrose 
[40]. Detergent extraction was carried out for 10 min on 
ice using 1.0% (v/v)  Triton X-100, 4 mM EGTA, 2 mM 
MgCI 2, 0.1 M KC1, 60 mM Pipes, pH 6.9 [41]. Following 
these incubation procedures, the suspensions were cen- 
trifuged for 20 min at 150000 X g and the resulting super- 
natant and pellet fractions then electrophoretically sepa- 
rated and analysed using immunoblot analysis. 
2.5. Gel electrophoresis and immunoblot analysis 
Sodium dodecyl sulfate polyacrylamide gel elec- 
trophoresis was performed according to Laemmli [42] at a 
constant setting of 200 V using 1.5 mm-thick 3-12% 
gradient gels. Electrophoretically separated proteins were 
transferred to nitrocellulose membranes for 90 min at 100 
V by the method of Towbin et al. [43]. Staining of 
immunoblots was performed using 4-chloronaphthol as a 
substrate [44]. When the same blot was stained with sev- 
eral different antibodies, the nitrocellulose membrane was 
sequentially stained with the respective primary antibodies 
and re-incubated with 5% (w/v) non-fat dry milk in 
phosphate-buffered saline between different applications. 
This procedure kept non-specific background staining to a
minimum and allowed the comparison of the intensity of 
antibody staining to muscle membrane proteins of greatly 
differing abundance. Protein concentration was determined 
by the method of Bradford [45] with bovine serum albumin 
as a standard. 
MUSCLE 
t Differential 
Centrifugation 
I iicrosomes I 
~ .6M KCI 
Washing 
I KCl-washed iicrosomes I 
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r ~lr ~ Sarcoplasmic Triads ~ Reticulum 
I Crude Surface Membrane I 
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Immobilized Vesicles 
SARCOLEMMA 
Fig. 1. Flow chart of the isolation of skeletal muscle sarcolemma. 
Overview summarising the different steps in the isolation of highly 
purified skeletal muscle sarcolemma vesicles used in this study to charac- 
terise low abundance proteins of the muscle periphery. Purification 
includes differential centrifugation, KCI washing, sucrose density gradi- 
ent centrifugation, lectin agglutination and detergent washing of immo- 
bilised sarcolemma vesicles. 
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differences in density and binding properties to lectins. A 
very comparable protein pattern was present following 
electrophoretic transfer as shown in the Ponceau-S-Red 
stained blot (Fig. 2), which is an important prerequisite for 
a successful immunoblot analysis of extremely low abun- 
dance muscle membrane proteins. The protein band of 
apparent 115 kDa which represents the CaZ+-ATPase of 
the sarcoplasmic reticulum [46] is greatly reduced in 
lectin-agglutinated sarcolemma vesicles. 
3.2. Comparative immunoblot analysis of muscle mem- 
branes 
To demonstrate he efficiency of the subcellular frac- 
tionation procedure involved in the isolation of vesicles 
derived from the sarcoplasmic reticulum, the transverse 
tubular membrane system, the triad junctions and the 
sarcolemma,  comparative immunoblot analysis was per- 
formed. Strong staining with monoclonal antibody IIID5, 
highly specific for the a 1-subunit of the transverse tubular 
dihydropyridine r ceptor, was found only in purified trans- 
verse tubules (Fig. 2) and to a lesser extent in the triad 
fraction, which consists of junctions between the terminal 
cisternae of the sarcoplasmic reticulum and the transverse 
tubules. Very low staining for the dihydropyridine r ceptor 
was observed in lectin-agglutinated sarcolemma vesicles 
(Fig. 2) indicating the low abundance of transverse tubular 
vesicles in the purified sarcolemma fraction. By contrast, 
the Na+/K+-ATPase, an enzyme found both in the sar- 
colemma nd to a lesser extent in the transverse tubules as 
judged by immunofluorescence microscopy [20], was found 
to be enriched in the sarcolemma and also present in the 
transverse tubules (Fig. 2). Following this initial analysis, 
we then checked whether immunoblotting was sensitive 
enough to recognise the distribution of extremely low 
abundance muscle membrane proteins. Prior to staining 
with antibodies to ecto-5'nucleotidase nd calmodulin-sen- 
sitive CaZ+-ATPase, blots were stained with more abun- 
dant and well established markers of the muscle cell 
periphery. Dystrophin and its associated glycoprotein of 43 
kDa, named 13-dystroglycan, strongly labelled the sar- 
colemma fraction (Figs. 3 and 4) demonstrating the good 
separation of transverse tubules and sarcolemma using the 
lectin agglutination technique. 
In skeletal muscle, insulin stimulates the translocation 
of glucose transporter p oteins from an intracellular vesicle 
pool to the sarcolemma [47]. A major component of these 
glucose transporter-enriched vesicles is a glycoprotein of 
160 kDa which binds to wheat germ agglutinin [48]. Thus, 
lectin agglutination of sarcolemma vesicles using purified 
wheat germ agglutinin could result in the co-isolation of 
these intracellular vesicles. To study potential contamina- 
tion of sarolemma vesicles with intracellular membrane 
structures originally derived from glucose transporter-con- 
taining vesicles, we investigated the subcellular distribu- 
tion of the glucose transporter. Antibody staining to iso- 
form GLUT-4 of the glucose transporter was found exclu- 
sively in the triad fraction (Fig. 3). Thus, vesicles contain- 
ing the glucose transporter, potentially co-agglutinated 
and/or entrapped within larger plasmalemma vesicles, do 
not appear to contaminate the lectin-agglutinated and de- 
tergent-washed sarcolemma fraction. 
3.3. Immunoblotting of low abundance surface markers 
Figs. 3 and 4 demonstrate hat antibody binding to the 
low abundance nzymes ecto-5'nucleotidase nd calmod- 
ulin-sensitive Ca2+-ATPase can be visualised using 4-chlo- 
224 
10g 
72 
46 
2¢J 
Coomassie Ponceau Na/K-ATPase 
q 
DHP-R 
1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 
Fig. 2. Comparative immunoblot analysis of subeellular muscle fractions. Shown is a Coomassie brilliant blue stained gel, a Ponceau-S-Red stained 
nitrocellulose blot and two identical immunoblots stained with antibodies to the Na+/K+-ATPase and the transverse tubular dihydropyridine r ceptor 
(DHP-R). The Coomassie-stained geland the Ponsceau-stained transfer clearly demonstrate he differences in the protein band pattern of highly purified 
sarcolemma (lane 4) as compared to the other three main types of skeletal muscle membranes, i.e., sarcoplasmic reticulum (lane 1), triad junctions (lane 2), 
and transverse tubules (lane 3). Since sarcolemma vesicles label strongly for the Na+/K+-ATPase but only weakly for the dihydropyridine r ceptor, a
good separation between transverse tubules and plasma membrane vesicles was achieved using lectin agglutination i combination with a low detergent 
washing step. Molecular mass markers (× 10 -3) are indicated on the left. 
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ronaphthol as a substrate. Antibodies used were directed 
against rat liver ecto-5' nucleotidase and human erythrocyte 
calmodulin-sensitive Ca 2+-ATPase. Both antibodies 
cross-reacted with rabbit skeletal muscle membranes. 
Staining was weak but distinctive and it visualised protein 
bands at the appropriate molecular masses of apparent 70 
kDa and 140 kDa for 5'nucleotidase [35] and the calmod- 
ulin-sensitive CaZ+-ATPase [49], respectively. Since these 
two proteins are established plasma membrane markers, 
this result indicated that the sarcolemma fraction isolated 
as described above is enriched enough in surface compo- 
nents of low density that it could also be used to charac- 
terise the low abundance dystrophin-related protein 
utrophin. As an internal standard, both blots shown in Figs. 
3 and 4 were also stained for the Na+/K+-ATPase to 
outline the extent of labelling of surface membranes by a 
relatively abundant protein. The weak Na+/K+-ATPase 
band of apparent 110 kDa in the transverse tubules fraction 
is most likely depressed ue to the presence of the large 
sarcoplasmic reticulum CaZ+-ATPase of apparent 115 kDa, 
In contrast, the lane with purified sarcolemma is essen- 
tially free of contaminating sarcoplasmic reticulum Ca 2+- 
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Fig. 3. Immunodetection of 5'nucleotidase in skeletal muscle sar- 
colemma. Shown is an immunoblot analysis of subcellular fractions 
isolated from skeletal muscle homogenates. Vesicles derived from the 
sarcoplasmic reticulum (lane l), the triad junctions (lane 2), the trans- 
verse tubular membrane system (lane 3) and the sarcolemma (l ne 4) 
were analysed using antibodies to the surface membrane marker dys- 
trophin, the internal vesicle marker glucose transporter (GLUT), and the 
Na+/K+-ATPase, an enzyme present both in he sarcolemma and to a 
lesser extent in the transverse tubules. After staining with these mark rs, 
which were used as an internal standard for the separation f muscle 
membranes, the blot was stained using antibodies toecto-5'nucleotidase 
(5'NTase). Immunodetection of this low abundance surface membrane 
marker was found to be restricted tothe sarcolemma fr ction. Molecular 
mass markers (× 10-3) are indicated on the left. 
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Fig. 4. Immunodetection of calmodulin-sensitive Ca 2 +-ATPase in skeletal 
muscle sarcolemma. Shown is an immunoblot analysis of ubcellular 
fractions isolated from skeletal muscle homogenates. Vesicles derived 
from the sarcoplasmic reticulum (lane 1), the triad junctions (lane 2), the 
transverse tubular membrane system (lane 3) and the sarcolemma (l ne 4) 
were analysed using antibodies to surface membrane markers dystrophin, 
Na+/K+-ATPase, and the dystrophin-associated glycoprotein of 43 kDa 
(43-DAG), also called 13-dystroglycan. After staining with these markers, 
which were used as an internal standard for the separation f muscle 
membranes, the blot was stained using antibodies to the calmodulin-sensi- 
tive Ca2+-ATPase (Ca-ATPase). Immunodetection of this surface mem- 
brane marker was found to be restricted tothe sarcolemma establishing 
that this subcellular fraction is enriched enough in membrane vesicl s 
derived from the muscle periphery tobe used in the analysis of extremely 
low abundance proteins. Molecular mass markers (× 10 ~) are indicated 
on the left. 
ATPase and thus the Na+/K+-ATPase is represented by a 
straight protein band (Figs. 3 and 4). 
3.4. Analysis of utrophin in sarcolemma following deter- 
gent extraction 
Since dystrophin is an established component of the 
subsarcolemmal muscle membrane fraction and exhibits 
biochemical properties typical of a cytoskeletal compo- 
nent, we performed a comparative biochemical analysis of 
utrophin and dystrophin. One well recognised criterion for 
determining whether a protein is a component of the 
membrane cytoskeleton is its relative insolubility in high 
concentrations of a non-ionic detergent such as Triton 
X-100 [41,50]. Fig. 5 shows the immunoblotting of puri- 
fied sarcolemma vesicles with respect o dystrophin and 
utrophin. The antibodies used are against the extreme 
C-termini of both proteins and, following affinity purifica- 
tion, they do not cross-react with each other [20]. Fig. 5 
demonstrates that utrophin is enriched enough in the agglu- 
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tinated and detergent-washed surface membrane fraction to 
be analysed. Thus, vesicular structures derived from the 
postsynaptic membrane of the neuromuscular junction must 
be relatively enriched in the sarcolemma fraction purified 
as described above. Dystrophin, which comprises approxi- 
mately 2% of skeletal muscle sarcolemma [33] and 5% of 
the subsarcolemmal cytoskeleton [36], is easily visualised 
using immunoblotting (Figs. 5 and 6). In contrast, 
immunostaining for utrophin is not as intensive as that 
observed for the more abundant protein dystrophin and 
immunodetection f utrophin also exhibits higher non- 
specific background staining (Figs. 5 and 6). However, 
previous tudies [20,23] have shown that these differences 
in immunoreactivity are most likely due to a variance in 
abundance of these two isoforms in muscle membranes 
and are not based on differences in affinity of the two 
antibodies for their respective pitope(s). Labelling of the 
apparent 395 kDa utrophin band is distinct enough to 
analyse the biochemical properties of utrophin during es- 
tablished extraction procedures. Following incubation with 
relatively high concentrations of the non-ionic detergent 
Triton X-100, immunoblotting revealed that the majority 
of autosomally-encoded utrophin remains with the deter- 
gent-insoluble pellet (Fig. 5). It thus behaves in the same 
way as its X-chromosome-encoded isoform, the estab- 
lished membrane cytoskeletal component dystrophin (Fig. 
5). 
DYS DRP 
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Fig. 6. Immunodetection f utrophin in sarcolemma following alkaline 
extraction. Shown are two identical immunoblots stained with affinity- 
purified antibodies to dystrophin (DYS) and the dystrophin-related pro- 
tein utrophin (DRP). The majority of both proteins is found in the 
alkaline-extracted supernatant fraction (lane 3) as compared to the un- 
treated sarcolemma fraction (lane 1) and the non-extracted bilayer frac- 
tion (lane 2). Since extraction with alkaline solutions is an established 
method to remove tightly associated cytoskeletal components from the 
membrane [50], both proteins appear to be components of the subsar- 
colemmal cytoskeleton. Molecular mass markers (× 10 -~ ) are indicated 
on the left. 
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Fig. 5. [mmunodetection of utrophin in sarcolemma following extraction 
with a non-ionic detergent. Shown are two identical immunob]ots tained 
with affinity-purified antibodies to dystrophin (DYS) and the dystrophin- 
related protein utrophin (DRP). The majority of both proteins remains 
with the detergent-insoluble pellet (lane 2) as compared to the untreated 
sarcolemma fraction (lane 1) and the detergent-extracted supernatant 
fraction (lane 3). Since relative insolubility in the non-ionic detergent 
Triton X-100 is an established criterion for a membrane cytoskeletal 
protein [50], both proteins appear to be components of this sarcolemmal 
subfraction. Molecular mass markers (× 10-3) are indicated on the left. 
3.5. Analysis of utrophin in sarcolemma following alkaline 
extraction 
In stark contrast, when sarcolemma membranes were 
treated with an alkaline suspension, utrophin was released 
from the bilayer and immunoblotting showed most of the 
utrophin protein in the supernatant fraction (Fig. 6). Since 
it is well established that tightly associated membrane 
cytoskeletal proteins can be removed from the integral 
protein-containing bilayer by strong alkaline solutions 
[40,50], utrophin was demonstrated to exhibit biochemical 
properties typical for this class of proteins. Utrophin shares 
this behaviour with dystrophin, which is released in the 
same way into the supematant using pH 11 (Fig. 6). 
Consequently, both dystrophin and utrophin behave very 
similarly in biochemical terms as predicted by the high 
homology of their primary structures. The immunoblot 
analysis of these two dystrophin skeletal muscle isoforms 
also shows that both proteins, although differing in appar- 
ent molecular mass, exhibit a nearly identical mobility in 
sodium dodecyl sulfate polyacrylamide g l electrophoresis. 
Although utrophin has a lower apparent molecular mass of 
395 kDa [15] as compared to dystrophin of 427 kDa [1], it 
behaves electrophoretically as if it had a slightly higher 
molecular mass than dystrophin as judged by immuno- 
blotting of identically run gradient gels (Figs. 5 and 6). 
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4. Discussion 
The comparative immunoblot analysis presented in this 
study reveals that lectin-mediated aggregation i combina- 
tion with a low detergent washing step results in a remark- 
able enrichment of plasma membrane markers in the mus- 
cle surface membrane fraction. Since vesicles derived from 
the sarcoplasmic reticulum are by far the most abundant 
fraction in skeletal muscle homogenates, subcellular frac- 
tionation using conventional methodology, i.e. density gra- 
dient centrifugation, produces urface membrane fractions 
of only limited purity and yield [51]. Furthermore, sar- 
colemma vesicles isolated from skeletal muscle bundles by 
collagenase treatment exhibit considerable contamination 
with vesicles derived from transverse tubules [52]. These 
technical problems can be overcome by using lectin agglu- 
tination techniques. It is presumed that wheat germ agglu- 
tinin separates ubsets of vesicular muscle membrane 
structures due to the fact that this lectin interacts exclu- 
sively with specific carbohydrate chains on the outside of 
right-side-out sarcolemma vesicles [33,53]. 
Thus, lectin-agglutinated sarcolemma vesicles contain 
only low amounts of contamination from associated or 
trapped vesicles derived from the sarcoplasmic reticulum 
[37], the transverse tubular membrane system [38], triad 
junctions [39] or other internal membrane systems, i.e. 
glucose transporter-containing vesicles [47]. Washing of 
agglutinated vesicles with low concentrations of non-ionic 
detergent appears to greatly diminish the amount of trapped 
vesicles within the immobilised sarcolemma vesicles. The 
fact, that integral surface membrane proteins such as 13- 
dystroglycan and the Na+/K+-ATPase were clearly de- 
tected by immunoblotting following detergent washing, 
demonstrates that the low concentrations of Triton X-100 
used do not solubilise the sarcolemma membrane notice- 
ably. Our findings that typical surface membrane markers 
such as the ecto-5'nucleotidase nd the calmodulin-sensi- 
tive Ca 2 +-ATPase are enriched in the sarcolemma fraction, 
closely agrees with the biochemical analysis of aggluti- 
nated surface membrane vesicles of Klebl et al. [54]. 
Sarcolemma vesicles, purified as described previously [33], 
showed a high enzyme activity of the surface membrane 
marker Na+/K÷-ATPase and also exhibited a several-fold 
increase in [3H] saxitoxin binding, indicative of an enrich- 
ment of the sarcolemmal sodium channel in this fraction 
[54]. Thus, lectin agglutination is a rapid and convenient 
technique for the analysis of sarcolemma components in 
skeletal muscle and can be used in the study of low 
abundance plasma membrane proteins. 
Numerous studies into the biochemical properties of 
dystrophin were enabled ue to its relatively high concen- 
tration in the membrane cytoskeletal fraction of skeletal 
muscle as reviewed in [1-9]. By contrast, the restricted 
localisation of utrophin to the neuromuscular junction re- 
sults in an extremely low abundance of this protein in 
microsomal membranes [20]. This complicated a reliable 
and detailed analysis of this dystrophin-related protein 
using standard biochemical extraction procedures ince 
these techniques depend on the limitations of detection 
systems uch as immunoblotting. However, using highly 
purified surface membrane vesicles enriched enough in 
vesicles derived from the sarcolemma including the post- 
synaptic muscle membrane region belonging to the neuro- 
muscular junction, a comparative analysis of utrophin and 
dystrophin could be performed. Both proteins behaved in 
the same way with respect to alkaline extraction and 
treatment with a non-ionic detergent. These findings agree 
with the predicted primary structures of these two large 
muscle isoforms [2,12]. As reviewed by Carraway and 
Carothers-Carraway [50], membrane cytoskeletal proteins 
are easily extracted from the bilayer using strong alkaline 
solutions, as was found to be the case with utrophin. 
However, detergent treatment using non-ionic components 
such as Triton X-100 solubilises integral membrane pro- 
teins but membrane cytoskeletal proteins typically remain 
with the insoluble pellet [50]. Since utrophin was detected 
in the detergent-insoluble pellet, this biochemical property 
also agreed with its proposed role as a membrane cyto- 
skeletal component of the neuromuscular junction. 
The confirmation that utrophin indeed exhibits proper- 
ties typical of a membrane cytoskeletal protein is impor- 
tant in two ways. Firstly, it s rengthens the proposed model 
of the structure of the neuromuscular junction and the 
mechanism of acetylcholine receptor clustering and sec- 
ondly, it has important implications for potential replace- 
ment therapies of dystrophin i  dystrophic muscle fibres. It 
is clearly established now that utrophin co-localises with 
clustered nicotinic acetylcholine r ceptors at the neuromus- 
cular junction [20-22] and that the utrophin-associated 
glycoprotein e~-dystroglycan is an agrin receptor [24-26]. 
In addition, recent studies by Cohen et al. [55] suggest that 
utrophin and its associated components might act as a 
diffusion trap which participates in the anchoring and 
recruitment of acetylcholine r ceptors during clustering in 
the synapse. Hence, utrophin appears to be a membrane 
cytoskeletal protein that performs the function(s) of dys- 
trophin at the neuromuscular junction. Since utrophin is
not restricted to the neuromuscular junction in dystrophic 
and regenerating skeletal muscle fibres, but is also present 
in extra-junctional regions [28], the potential usage of 
utrophin over-expression in experimental gene therapy has 
been suggested [30]. Up-regulation of dystrophin isoforms 
to counteract the sarcolemmal instability observed in dys- 
trophin-deficient muscle fibres could be utilised in the 
treatment of Duchenne muscular dystrophy and related 
inherited isorders. That utrophin can substitute dystrophin 
in dystrophic muscle is indicated by studies of the dys- 
trophin-deficient mdx mouse mutant. Typically, mdx 
skeletal muscle exhibits a dramatic reduction of all compo- 
nents of the dystrophin-glycoprotein complex [56]. How- 
ever, extraoccular and toe muscles exhibit near normal 
levels of dystrophin-associated glycoproteins in the mdx 
222 K. Ohlendieck / Biochimica et Biophysica Acta 1283 (1996) 215-222 
muscle periphery [23]. Since extra-junctional utrophin co- 
localises with dystrophin-associated glycoproteins in these 
mdx muscle groups, it appears very likely that utrophin 
anchors these components in dystrophin-deficient sar- 
colemma. In addition, Winder et al. [31] could demonstrate 
that expressed regions of the predicted actin-binding do- 
main of utrophin bind to F-actin. Therefore, it is very 
likely that autosomally-encoded utrophin is capable of 
performing a functional equivalent role to X- 
chromosome-encoded ystrophin. 
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